pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
0cfcd041-582a-44eb-a394-39c3fe21bdc1
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-17 22:07:20
Income (reported)
—
Expenses (reported)
$2,990,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

KAISER FOUNDATION HEALTH PLAN INC.

Contact
JULIE H. STOSS
Phone
+1 202-216-4707
Address
zip:94612, city:Oakland, state:CA, street:ONE Kaiser Plaza, Ordway Building 27th Floor

Client

KAISER FOUNDATION HEALTH PLAN INC

State
CA
Country
US
Government-entity client
false
Effective date
2007-07-27

Issues lobbied + lobbyists

HCR — Health Issues

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822, Break Up Big Medicine Act

Lobbyists: MARY PRUDENCE FITZPATRICK; DAVID C BENNETT; BRENDAN DEVINE [new]; MARK HAYES

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105, No UPCODE Act

Lobbyists: MARY PRUDENCE FITZPATRICK; DAVID C BENNETT; BRENDAN DEVINE [new]; MARK HAYES

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) H. R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act)

Lobbyists: MARY PRUDENCE FITZPATRICK; DAVID C BENNETT; BRENDAN DEVINE [new]; MARK HAYES

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

Legislation and regulation related to funding, budget and appropriations. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75)

Lobbyists: MARY PRUDENCE FITZPATRICK; DAVID C BENNETT; BRENDAN DEVINE [new]; MARK HAYES

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.